Next Article in Journal
Non-Immersive Virtual Reality Telerehabilitation System Improves Postural Balance in People with Chronic Neurological Diseases
Previous Article in Journal
Widespread Intra- and Inter-Network Dysconnectivity among Large-Scale Resting State Networks in Schizophrenia
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
JCM
Volume 12
Issue 9
10.3390/jcm12093177
jcm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Correction to J. Clin. Med. 2022, 11(16), 4794.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Oweira et al. Kynurenine Is the Main Metabolite of Tryptophan Degradation by Tryptophan 2,3-Dioxygenase in HepaRG Tumor Cells. J. Clin. Med. 2022, 11, 4794

by
Hani Oweira
1,
Imad Lahdou
2,
Stefan Mehrle
2,
Elias Khajeh
3,
Rajan Nikbakhsh
3,
Omid Ghamarnejad
3,
Peter Terness
2,
Christoph Reißfelder
1,
Mahmoud Sadeghi
2 and
Ali Ramouz
3,*
1
Department of Surgery, Medical Faculty Mannheim, University of Heidelberg, 68167 Mannheim, Germany
2
Department of Transplantation Immunology, University of Heidelberg, 69120 Heidelberg, Germany
3
Department of General, Visceral, and Transplantation Surgery, University of Heidelberg, 69120 Heidelberg, Germany
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2023, 12(9), 3177; https://doi.org/10.3390/jcm12093177
Submission received: 9 February 2023 / Accepted: 14 March 2023 / Published: 28 April 2023
(This article belongs to the Section Immunology)
Versions Notes

Text Correction

There was an error in the original publication [1]. In all parts of the manuscript, the used cell line for the analyses was defined as “HepG2” instead of “HepaRG”. The corrections have been made to all sections of the manuscript by replacing “HepG2” with “HepaRG”.
The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Oweira, H.; Lahdou, I.; Mehrle, S.; Khajeh, E.; Nikbakhsh, R.; Ghamarnejad, O.; Terness, P.; Reißfelder, C.; Sadeghi, M.; Ramouz, A. Kynurenine Is the Main Metabolite of Tryptophan Degradation by Tryptophan 2,3-Dioxygenase in HepaRG Tumor Cells. J. Clin. Med. 2022, 11, 4794. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Oweira, H.; Lahdou, I.; Mehrle, S.; Khajeh, E.; Nikbakhsh, R.; Ghamarnejad, O.; Terness, P.; Reißfelder, C.; Sadeghi, M.; Ramouz, A. Correction: Oweira et al. Kynurenine Is the Main Metabolite of Tryptophan Degradation by Tryptophan 2,3-Dioxygenase in HepaRG Tumor Cells. J. Clin. Med. 2022, 11, 4794. J. Clin. Med. 2023, 12, 3177. https://doi.org/10.3390/jcm12093177

AMA Style

Oweira H, Lahdou I, Mehrle S, Khajeh E, Nikbakhsh R, Ghamarnejad O, Terness P, Reißfelder C, Sadeghi M, Ramouz A. Correction: Oweira et al. Kynurenine Is the Main Metabolite of Tryptophan Degradation by Tryptophan 2,3-Dioxygenase in HepaRG Tumor Cells. J. Clin. Med. 2022, 11, 4794. Journal of Clinical Medicine. 2023; 12(9):3177. https://doi.org/10.3390/jcm12093177

Chicago/Turabian Style

Oweira, Hani, Imad Lahdou, Stefan Mehrle, Elias Khajeh, Rajan Nikbakhsh, Omid Ghamarnejad, Peter Terness, Christoph Reißfelder, Mahmoud Sadeghi, and Ali Ramouz. 2023. "Correction: Oweira et al. Kynurenine Is the Main Metabolite of Tryptophan Degradation by Tryptophan 2,3-Dioxygenase in HepaRG Tumor Cells. J. Clin. Med. 2022, 11, 4794" Journal of Clinical Medicine 12, no. 9: 3177. https://doi.org/10.3390/jcm12093177

APA Style

Oweira, H., Lahdou, I., Mehrle, S., Khajeh, E., Nikbakhsh, R., Ghamarnejad, O., Terness, P., Reißfelder, C., Sadeghi, M., & Ramouz, A. (2023). Correction: Oweira et al. Kynurenine Is the Main Metabolite of Tryptophan Degradation by Tryptophan 2,3-Dioxygenase in HepaRG Tumor Cells. J. Clin. Med. 2022, 11, 4794. Journal of Clinical Medicine, 12(9), 3177. https://doi.org/10.3390/jcm12093177

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop